Press release
Non-alcoholic Steatohepatitis Treatment Market Size, Share, Global Trends, Major Key Players and Geographical Forecast Till 2027
According to the report, increasing investment by numerous pharmaceutical companies in the research and development activities of effective molecules will contribute to the NASH treatment market growth during the forecast period. Furthermore, robust pipeline candidates and rising demand for effective drugs for NASH will also fuel market growth in the coming years.
Get Sample PDF:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-alcoholic-steatohepatitis-treatment-market-100656
Top Leaders Overview:
Some of the leading companies in the global Non-alcoholic Steatohepatitis Treatment Market are
GENFIT
Intercept Pharmaceuticals, Inc.,
Galmed Pharmaceuticals Ltd.,
Bristol-Myers Squibb Company
Sirius Therapeutics
Conatus Pharmaceuticals Inc
Galectin Therapeutics Inc
Immuron, Akcea Therapeutics among others
The report provides an elaborate analysis of the global non-alcoholic steatohepatitis treatment market. It also offers detailed insights regarding various aspects of the market, namely, growth drivers, challenges, upcoming trends, ongoing developments, key market players, and restraints. The competitive landscape of the global NASH treatment market, as well as the dominant regions, are presented in the report.
Ability to Reduce Weight to Fuel Glucagon-like Peptide-1 Receptor Drugs Segment
On the bases of drug class, the global NASH treatment market is divided into PPAR agonists, FXR-bile acid axis, anti-oxidants, GLP-1/DPP-4/SGLT-2 agent, anti-inflammatory agents, anti-fibrotic, and others. Out of these, the Glucagon-like peptide-1 receptor (GLP-1R) drugs are projected to acquire the largest global non-alcoholic steatohepatitis treatment market share during the forthcoming years. It would occur because these agonists drugs aid in decreasing weight, which further reduces fast accumulation in the liver and prevents a person from NASH.
Rising Incidence of Fatty Liver Disease in the U.S. to Boost Growth in North America
The global non-alcoholic steatohepatitis treatment market is geographically categorized into the Middle East and Africa, Europe, Latin America, North America, and Asia Pacific. Amongst these regions, North America is anticipated to lead the global NASH treatment market in the coming years. It would occur due to the increasing prevalence of fatty liver disease amongst the population in the U.S. The National Medical Advisory Committee (NAMC) estimated that at present, approximately 30 million people in the U.S. are diagnosed with NASH.
In Asia Pacific, on the other hand, the NASH treatment market is expected to grow at a rapid rate during the forecast period. Growing patient pool, rising demand for cost-effective treatment options, and overconsumption of unhealthy food are three of the most significant factors that will contribute to the market growth in this region.
Intercept Pharmaceuticals Submits New Drug Application to FDA for Obeticholic Acid
Intercept Pharmaceuticals, a biopharmaceutical company, based in the U.S., announced that it has submitted its New Drug Application (NDA) for obeticholic acid (OCA) to the FDA in September 2019. It is meant for the treatment of patients suffering from fibrosis because of NASH. OCA is the only therapy to meet the endpoint of a Phase 3 study in patients living with NASH. The company has asked for a Priority Review for the NDA. If approved, it would result in a six-month review period. The submission is based on the results from the Phase 3 Regenerate study in those affected by liver fibrosis due to NASH. Regenerate is a Phase 3, multicenter, randomized, placebo-controlled, and double-blind study that assesses the efficacy and safety of OCA on clinical outcomes in NASH affected patients.
Fortune Business Insights profiles some of the prominent organizations dominating the global non-alcoholic steatohepatitis (NASH) treatment market. They are given below:
Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/non-alcoholic-steatohepatitis-treatment-market-100656
Segmentation of the Non-alcoholic Steatohepatitis (NASH) Treatment Market
By Drug Class
PPAR agonists
FXR-bile acid axis
Anti-oxidants
GLP-1/DPP-4/SGLT-2 agent
Anti-inflammatory agents
Anti-fibrotic
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
https://www.businessresearchinsights.com/market-reports/giant-magnetoresistive-sensor-market-100006
https://www.businessresearchinsights.com/market-reports/magnetic-cartridges-market-100061
https://www.businessresearchinsights.com/market-reports/gallium-arsenide-gaas-wafer-market-100045
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis Treatment Market Size, Share, Global Trends, Major Key Players and Geographical Forecast Till 2027 here
News-ID: 2562240 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd.
Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% …
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period.
Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacement…
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca …
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023.
Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032."
Request a Free Sample…
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan …
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period.
Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear is…
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- …
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period.
Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost the…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
